Edwards Lifesciences | EW - Devedores Comerciais

Preço das Ações
82.28
Mudança Diária
-1.18 -1.41%
Mensal
3.50%
Anual
7.87%
Q2 Previsão
82.35




Devedores Comerciais Alterar Data
Abbott USD 10.57B 171M 2025-12
Artivion USD 103.68M 6.31M 2025-12
AtriCure USD 66.65M 3.67M 2025-12
Baxter International USD 2.01B 231M 2025-12
Becton, Dickinson and Co. USD 2.51B 486M 2025-12
Boston Scientific USD 2.93B 98M 2025-12
Cooper Companies USD 807.1M 21.9M 2025-12
Dexcom USD 1.28B 167.3M 2025-12
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Globus Medical USD 743.66M 55.54M 2025-12
ICU Medical USD 180.52M 11.03M 2025-12
Inogen USD 37.09M 4.11M 2024-06
Insulet USD 516.9M 54.7M 2025-12
Integra LifeSciences USD 278.85M 16.69M 2025-12
Intuitive Surgical USD 1.6B 68.3M 2026-03
J&J USD 21.33B 3.72B 2025-12
Masimo USD 391.9M 36M 2025-12
Medtronic USD 6.36B 30M 2025-12
Merit Medical Systems USD 223.61M 7.9M 2025-12
Stryker USD 4.04B 396M 2025-12
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teleflex USD 345.58M 247.07M 2025-12
Zimmer Biomet Holdings USD 1.7B 106.1M 2025-12